Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation

Free Radical Biology and Medicine

Volumn 52, Issue 2, 2012, Pages 266-280

  Greig, Fiona H ^a   Kennedy, Simon ^a   Spickett, Corinne M ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Anti inflammatory effects; Apoptosis; Cell proliferation; Chlorinated lipids; Free radicals; Leukocyte endothelial adhesion; Oxidized phospholipids

Indexed keywords

CYTOKINE; GUANOSINE TRIPHOSPHATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SCAVENGER RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TOLL LIKE RECEPTOR;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENZYME ACTIVATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE; LIPID OXIDATION; MACROPHAGE; MICROVASCULAR ENDOTHELIAL CELL; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; CELL MEMBRANE; CELL PROLIFERATION; CHLOROHYDRINS; ENDOTHELIUM; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

ANIMALIA;

EID: 84855432213     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.10.481     Document Type: Review

References (190)

1. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
2. N. Leitinger The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans Subcell. Biochem. 49 2008 325 350
3. V.N. Bochkov, O.V. Oskolkova, K.G. Birukov, A.L. Levonen, C.J. Binder, and J. Stockl Generation and biological activities of oxidized phospholipids Antioxid. Redox Signal. 12 2010 1009 1059
4. J. Huber, A. Vales, G. Mitulovic, M. Blumer, R. Schmid, J.L. Witztum, B.R. Binder, and N. Leitinger Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions Arterioscler. Thromb. Vasc. Biol. 22 2002 101 107 (Pubitemid 34076239)
5. C.M. Spickett, I. Wiswedel, W. Siems, K. Zarkovic, and N. Zarkovic Advances in methods for the determination of biologically relevant lipid peroxidation products Free Radic. Res. 44 2010 1172 1202
6. G.O. Fruhwirth, A. Loidl, and A. Hermetter Oxidized phospholipids: from molecular properties to disease Biochim. Biophys. Acta 1772 2007 718 736 (Pubitemid 46891216)
7. M. Conrad, M. Schneider, A. Seiler, and G.W. Bornkamm Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals Biol. Chem. 388 2007 1019 1025 (Pubitemid 47584306)
8. G. Spiteller Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products Free Radic. Biol. Med. 41 2006 362 387 (Pubitemid 44037278)
9. A.D. Watson, N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J.L. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, G. Subbanagounder, A.M. Fogelman, and J.A. Berliner Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 272 1997 13597 13607 (Pubitemid 27224791)
10. C.M. Spickett, and G. Dever Studies of phospholipid oxidation by electrospray mass spectrometry: from analysis in cells to biological effects Biofactors 24 2005 17 31 (Pubitemid 41754366)
11. D. Lapenna, S.D. Pierdomenico, G. Ciofani, S. Ucchino, M. Neri, M.A. Giamberardino, and F. Cuccurullo Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques Free Radic. Biol. Med. 42 2007 492 498 (Pubitemid 46162117)
12. S. Trudel, M. Kelly, J. Fritsch, T. Nguyen-Khoa, P. Therond, M. Couturier, M. Dadlez, J. Debski, L. Touqui, B. Vallee, M. Ollero, A. Edelman, and F. Brouillard Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge PLoS One 4 2009 e6075
13. A. Isik, S.S. Koca, B. Ustundag, H. Celik, and A. Yildirim Paraoxonase and arylesterase levels in rheumatoid arthritis Clin. Rheumatol. 26 2007 342 348 (Pubitemid 46486964)
14. L.P. Precourt, D. Amre, M.C. Denis, J.C. Lavoie, E. Delvin, E. Seidman, and E. Levy The three-gene paraoxonase family: physiologic roles, actions and regulation Atherosclerosis 214 2011 20 36
15. I.A. Pereira, and E.F. Borba Multiple factors determine the increased prevalence of atherosclerosis in rheumatoid arthritis Acta Reumatol. Port. 33 2008 47 55
16. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
17. J.L. Witztum, and D. Steinberg Role of oxidized low density lipoprotein in atherogenesis J. Clin. Invest. 88 1991 1785 1792
18. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic. Biol. Med. 28 2000 1815 1826 (Pubitemid 30628668)
19. H.F. Hoff, J. O'Neil, Z. Wu, G. Hoppe, and R.L. Salomon Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 23 2003 275 282 (Pubitemid 36231940)
20. A. Ravandi, S. Babaei, R. Leung, J.C. Monge, G. Hoppe, H. Hoff, H. Kamido, and A. Kuksis Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development Lipids 39 2004 97 109 (Pubitemid 38480939)
21. B. Davis, G. Koster, L.J. Douet, M. Scigelova, G. Woffendin, J.M. Ward, A. Smith, J. Humphries, K.G. Burnand, C.H. Macphee, and A.D. Postle Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein J. Biol. Chem. 283 2008 6428 6437
22. F. Chabot, J.A. Mitchell, J.M. Gutteridge, and T.W. Evans Reactive oxygen species in acute lung injury Eur. Respir. J. 11 1998 745 757 (Pubitemid 28194873)
23. J.D. Lang, P.J. McArdle, P.J. O'Reilly, and S. Matalon Oxidant-antioxidant balance in acute lung injury Chest 122 2002 314S 320S (Pubitemid 36043021)
24. T. Nakamura, P.M. Henson, and R.C. Murphy Occurrence of oxidized metabolites of arachidonic acid esterified to phospholipids in murine lung tissue Anal. Biochem. 262 1998 23 32 (Pubitemid 28440683)
25. I. Matot, Y. Manevich, A.B. Al-Mehdi, C. Song, and A.B. Fisher Fluorescence imaging of lipid peroxidation in isolated rat lungs during nonhypoxic lung ischemia Free Radic. Biol. Med. 34 2003 785 790 (Pubitemid 36288543)
26. V.A. Tyurin, Y.Y. Tyurina, M.Y. Jung, M.A. Tungekar, K.J. Wasserloos, H. Bayir, J.S. Greenberger, P.M. Kochanek, A.A. Shvedova, B. Pitt, and V.E. Kagan Mass-spectrometric analysis of hydroperoxy- and hydroxy-derivatives of cardiolipin and phosphatidylserine in cells and tissues induced by pro-apoptotic and pro-inflammatory stimuli J Chromatogr B Analyt Technol Biomed Life Sci 877 2009 2863 2872
27. J.P. Fessel, N.A. Porter, K.P. Moore, J.R. Sheller, and L.J. Roberts II Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension Proc. Natl. Acad. Sci. U. S. A. 99 2002 16713 16718 (Pubitemid 36034038)
28. N. Yoshimi, Y. Ikura, Y. Sugama, S. Kayo, M. Ohsawa, S. Yamamoto, Y. Inoue, K. Hirata, H. Itabe, J. Yoshikawa, and M. Ueda Oxidized phosphatidylcholine in alveolar macrophages in idiopathic interstitial pneumonias Lung 183 2005 109 121 (Pubitemid 41264740)
29. D. Cruz, A.D. Watson, C.S. Miller, D. Montoya, M.T. Ochoa, P.A. Sieling, M.A. Gutierrez, M. Navab, S.T. Reddy, J.L. Witztum, A.M. Fogelman, T.H. Rea, D. Eisenberg, J. Berliner, and R.L. Modlin Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy J. Clin. Invest. 118 2008 2917 2928
30. B.J. Van Lenten, A.C. Wagner, M. Navab, G.M. Anantharamaiah, E.K. Hui, D.P. Nayak, and A.M. Fogelman D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes Circulation 110 2004 3252 3258 (Pubitemid 39525074)
31. A.A. Farooqui, and L.A. Horrocks Lipid peroxides in the free radical pathophysiology of brain diseases Cell. Mol. Neurobiol. 18 1998 599 608 (Pubitemid 29012939)
32. C. Jolivalt, B. Leininger-Muller, P. Bertrand, R. Herber, Y. Christen, and G. Siest Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids Free Radic. Biol. Med. 28 2000 129 140 (Pubitemid 30045581)
33. B.M. Ross, A. Moszczynska, J. Erlich, and S.J. Kish Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease Neuroscience 83 1998 791 798 (Pubitemid 28068899)
34. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Hoftberger, G. Botond, H. Esterbauer, C.J. Binder, J.L. Witztum, and H. Lassmann Oxidative damage in multiple sclerosis lesions Brain 134 2011 1914 1924
35. 2-derived adducts of proteins correlate with Alzheimer's disease severity J. Neurochem. 94 2005 1140 1145 (Pubitemid 41170600)
36. J.P. Fessel, C. Hulette, S. Powell, L.J. Roberts, and J. Zhang II Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease J. Neurochem. 85 2003 645 650 (Pubitemid 36531927)
37. B. Govindarajan, J. Laird, R.G. Salomon, and S.K. Bhattacharya Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork Biochemistry 47 2008 817 825 (Pubitemid 351195453)
38. E. Al-Shawaf, J. Naylor, H. Taylor, K. Riches, C.J. Milligan, D. O'Regan, K.E. Porter, J. Li, and D.J. Beech Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 30 2010 1453 1459
39. J. Wang, B. Hu, L. Kong, H. Cai, and C. Zhang Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation Clin. Chim. Acta 390 2008 67 71
40. J.T. Cvetkovic, S. Wallberg-Jonsson, E. Ahmed, S. Rantapaa-Dahlqvist, and A.K. Lefvert Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis Rheumatology (Oxford) 41 2002 988 995
41. F. Gruber, O. Oskolkova, A. Leitner, M. Mildner, V. Mlitz, B. Lengauer, A. Kadl, P. Mrass, G. Kronke, B.R. Binder, V.N. Bochkov, N. Leitinger, and E. Tschachler Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells J. Biol. Chem. 282 2007 16934 16941 (Pubitemid 47093222)
42. B.H. Hahn, and M. McMahon Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies Lupus 17 2008 368 370 (Pubitemid 351798709)
43. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
44. S. Tsimikas, S. Kiechl, J. Willeit, M. Mayr, E.R. Miller, F. Kronenberg, Q. Xu, C. Bergmark, S. Weger, F. Oberhollenzer, and J.L. Witztum Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study J. Am. Coll. Cardiol. 47 2006 2219 2228 (Pubitemid 43795077)
45. G. Subbanagounder, A.D. Watson, and J.A. Berliner Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities Free Radic. Biol. Med. 28 2000 1751 1761 (Pubitemid 30628662)
46. E.A. Podrez, T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P.J. Finton, B.R. Curtis, J. Chen, R. Zhang, R.L. Silverstein, and S.L. Hazen Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat. Med. 13 2007 1086 1095 (Pubitemid 47517507)
47. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 25 2005 1102 1111 (Pubitemid 40776595)
48. E.A. Podrez, H.M. Abu-Soud, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic. Biol. Med. 28 2000 1717 1725 (Pubitemid 30628658)
49. C.C. Winterbourn, J.J. van den Berg, E. Roitman, and F.A. Kuypers Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid Arch. Biochem. Biophys. 296 1992 547 555
50. C.M. Spickett Chlorinated lipids and fatty acids: an emerging role in pathology Pharmacol. Ther. 115 2007 400 409 (Pubitemid 47362376)
51. A. Jerlich, A.R. Pitt, R.J. Schaur, and C.M. Spickett Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS Free Radic. Biol. Med. 28 2000 673 682 (Pubitemid 30171280)
52. O.M. Panasenko, H. Spalteholz, J. Schiller, and J. Arnhold Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines Free Radic. Biol. Med. 34 2003 553 562 (Pubitemid 36254829)
53. K.R. Wildsmith, C.J. Albert, D.S. Anbukumar, and D.A. Ford Metabolism of myeloperoxidase-derived 2-chlorohexadecanal J. Biol. Chem. 281 2006 16849 16860
54. C.J. Albert, J.R. Crowley, F.F. Hsu, A.K. Thukkani, and D.A. Ford Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens-identification of 8-chlorohexadecanal J. Biol. Chem. 276 2001 23733 23741
55. Fernandes, R. M.; Silva, N. P.; Sato, E. I. Increased myeloperoxidase plasma levels in rheumatoid arthritis. Rheumatol. Int. (in press). doi: 10.1007/s00296-011-1810-5.
56. M. Minohara, T. Matsuoka, W. Li, M. Osoegawa, T. Ishizu, Y. Ohyagi, and J. Kira Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity J. Neuroimmunol. 178 2006 156 160 (Pubitemid 44307343)
57. S. Oottamasathien, W. Jia, L. McCoard, S. Slack, J. Zhang, A. Skardal, K. Job, T.P. Kennedy, R.O. Dull, and G.D. Prestwich A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides J. Urol. 186 4 Suppl. 2011 1684 1692
58. A. Mohamadkhani, F. Rastgar Jazii, K. Sayehmiri, S. Jafari-Nejad, L. Montaser-Kouhsari, H. Poustchi, and G. Montazeri Plasma myeloperoxidase activity and apolipoprotein a-1 expression in chronic hepatitis B patients Arch. Iran. Med. 14 2011 254 258
59. S.Z. Samsamshariat, G. Basati, A. Movahedian, M. Pourfarzam, and N. Sarrafzadegan Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease Biomark. Med. 5 2011 377 385
60. S. Baldus, C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, T. Munzel, M.L. Simoons, and C.W. Hamm Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445 (Pubitemid 37176448)
61. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 94 1994 437 444 (Pubitemid 24218123)
62. M.L. Brennan, M.S. Penn, F. Van Lente, V. Nambi, M.H. Shishehbor, R.J. Aviles, M. Goormastic, M.L. Pepoy, E.S. McErlean, E.J. Topol, S.E. Nissen, and S.L. Hazen Prognostic value of myeloperoxidase in patients with chest pain N. Engl. J. Med. 349 2003 1595 1604 (Pubitemid 37288567)
63. A.K. Thukkani, J. McHowat, F.-F. Hsu, M.-L. Brennan, S.L. Hazen, and D.A. Ford Identification of α-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133 (Pubitemid 38031803)
64. A.K. Thukkani, B.D. Martinson, C.J. Albert, G.A. Vogler, and D.A. Ford Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2955 H2964
65. A. Ullen, G. Fauler, H. Kofeler, S. Waltl, C. Nusshold, E. Bernhart, H. Reicher, H.J. Leis, A. Wintersperger, E. Malle, and W. Sattler Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo Free Radic. Biol. Med. 49 2010 1655 1665
66. M.C. Messner, C.J. Albert, J. McHowat, and D.A. Ford Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions Lipids 43 2008 243 249
67. G.H. Gibbons, and V.J. Dzau The emerging concept of vascular remodeling N. Engl. J. Med. 330 1994 1431 1438 (Pubitemid 24139238)
68. P. Fu, and K.G. Birukov Oxidized phospholipids in control of inflammation and endothelial barrier Transl. Res. 153 2009 166 176
69. A.C. Doran, N. Meller, and C.A. McNamara Role of smooth muscle cells in the initiation and early progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 28 2008 812 819 (Pubitemid 351544093)
70. N.A. Pidkovka, O.A. Cherepanova, T. Yoshida, M.R. Alexander, R.A. Deaton, J.A. Thomas, N. Leitinger, and G.K. Owens Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro Circ. Res. 101 2007 792 801 (Pubitemid 350287194)
71. O.A. Cherepanova, N.A. Pidkovka, O.F. Sarmento, T. Yoshida, Q. Gan, E. Adiguzel, M.P. Bendeck, J. Berliner, N. Leitinger, and G.K. Owens Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration Circ. Res. 104 2009 609 618
72. L.J. van Tits, R. Stienstra, P.L. van Lent, M.G. Netea, L.A. Joosten, and A.F. Stalenhoef Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2 Atherosclerosis 214 2011 345 349
73. L.S. Graham, F. Parhami, Y. Tintut, C.M. Kitchen, L.L. Demer, and R.B. Effros Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss Clin. Immunol. 133 2009 265 275
74. N. Auge, V. Garcia, F. Maupas-Schwalm, T. Levade, R. Salvayre, and A. Negre-Salvayre Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways Arterioscler. Thromb. Vasc. Biol. 22 2002 1990 1995 (Pubitemid 36025204)
75. M.N. Chahine, D.P. Blackwood, E. Dibrov, M.N. Richard, and G.N. Pierce Oxidized LDL affects smooth muscle cell growth through MAPK-mediated actions on nuclear protein import J. Mol. Cell. Cardiol. 46 2009 431 441
76. S. Chatterjee, J.A. Berliner, G.G. Subbanagounder, A.K. Bhunia, and S. Koh Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation Glycoconj. J. 20 2004 331 338 (Pubitemid 39024041)
77. S.R. Johnstone, J. Ross, M.J. Rizzo, A.C. Straub, P.D. Lampe, N. Leitinger, and B.E. Isakson Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation Am. J. Pathol. 175 2009 916 924
78. A. Moumtzi, M. Trenker, K. Flicker, E. Zenzmaier, R. Saf, and A. Hermetter Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells J. Lipid Res. 48 2007 565 582 (Pubitemid 46397460)
79. G.O. Fruhwirth, A. Moumtzi, A. Loidl, E. Ingolic, and A. Hermetter The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells Biochim. Biophys. Acta 1761 2006 1060 1069 (Pubitemid 44354287)
80. M.E. Zettler, M.A. Prociuk, J.A. Austria, H. Massaeli, G. Zhong, and G.N. Pierce OxLDL stimulates cell proliferation through a general induction of cell cycle proteins Am. J. Physiol. Heart Circ. Physiol. 284 2003 H644 H653
81. S. Yu, S.L. Wong, C.W. Lau, Y. Huang, and C.M. Yu Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells Biochem. Biophys. Res. Commun. 407 2011 44 48
82. A. Bedel, A. Negre-Salvayre, S. Heeneman, M.H. Grazide, J.C. Thiers, R. Salvayre, and F. Maupas-Schwalm E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein Circ. Res. 103 2008 694 701
83. T. Senokuchi, T. Matsumura, M. Sakai, T. Matsuo, M. Yano, S. Kiritoshi, K. Sonoda, D. Kukidome, T. Nishikawa, and E. Araki Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein Atherosclerosis 176 2004 233 245 (Pubitemid 39369512)
84. Z. Mallat, and A. Tedgui Apoptosis in the vasculature: mechanisms and functional importance Br. J. Pharmacol. 130 2000 947 962 (Pubitemid 30453528)
85. M.R. Bennett, and J.J. Boyle Apoptosis of vascular smooth muscle cells in atherosclerosis Atherosclerosis 138 1998 3 9 (Pubitemid 28255149)
86. A. Loidl, E. Sevcsik, G. Riesenhuber, H.P. Deigner, and A. Hermetter Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells J. Biol. Chem. 278 2003 32921 32928 (Pubitemid 37055735)
87. A. Loidl, R. Claus, E. Ingolic, H.P. Deigner, and A. Hermetter Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells Biochim. Biophys. Acta 1690 2004 150 158 (Pubitemid 39299193)
88. D.X. Bu, M. Tarrio, E. Maganto-Garcia, G. Stavrakis, G. Tajima, J. Lederer, P. Jarolim, G.J. Freeman, A.H. Sharpe, and A.H. Lichtman Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation Arterioscler. Thromb. Vasc. Biol. 31 2011 1100 1107
89. J. Qin, F.D. Testai, S. Dawson, J. Kilkus, and G. Dawson Oxidized phosphatidylcholine formation and action in oligodendrocytes J. Neurochem. 110 2009 1388 1399
90. M.C. Clarke, T.D. Littlewood, N. Figg, J.J. Maguire, A.P. Davenport, M. Goddard, and M.R. Bennett Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration Circ. Res. 102 2008 1529 1538
91. H. Ait-Oufella, K. Kinugawa, J. Zoll, T. Simon, J. Boddaert, S. Heeneman, O. Blanc-Brude, V. Barateau, S. Potteaux, R. Merval, B. Esposito, E. Teissier, M.J. Daemen, G. Leseche, C. Boulanger, A. Tedgui, and Z. Mallat Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice Circulation 115 2007 2168 2177 (Pubitemid 46659069)
92. M.C. Clarke, S. Talib, N.L. Figg, and M.R. Bennett Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis Circ. Res. 106 2010 363 372
93. M.K. Chang, C.J. Binder, Y.I. Miller, G. Subbanagounder, G.J. Silverman, J.A. Berliner, and J.L. Witztum Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory J. Exp. Med. 200 2004 1359 1370 (Pubitemid 39657284)
94. C.C. Hsieh, M.H. Yen, H.W. Liu, and Y.T. Lau Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL Atherosclerosis 151 2000 481 491
95. S.J. Hardwick, L. Hegyi, K. Clare, N.S. Law, K.L. Carpenter, M.J. Mitchinson, and J.N. Skepper Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein J. Pathol. 179 1996 294 302 (Pubitemid 26266409)
96. R.S. Hundal, A. Gomez-Munoz, J.Y. Kong, B.S. Salh, A. Marotta, V. Duronio, and U.P. Steinbrecher Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels J. Biol. Chem. 278 2003 24399 24408 (Pubitemid 37548591)
97. H. Yang, and S.C. Chen The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL Eur. J. Pharmacol. 657 2011 126 130
98. D. Li, and J.L. Mehta Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors Arterioscler. Thromb. Vasc. Biol. 20 2000 1116 1122 (Pubitemid 30207591)
99. A. Pirillo, A. Reduzzi, N. Ferri, H. Kuhn, A. Corsini, and A.L. Catapano Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells Atherosclerosis 214 2011 331 337
100. J. Chen, J.L. Mehta, N. Haider, X. Zhang, J. Narula, and D. Li Role of caspases in ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells Circ. Res. 94 2004 370 376 (Pubitemid 38240729)
101. C. Nusshold, M. Kollroser, H. Kofeler, G. Rechberger, H. Reicher, A. Ullen, E. Bernhart, S. Waltl, I. Kratzer, A. Hermetter, H. Hackl, Z. Trajanoski, A. Hrzenjak, E. Malle, and W. Sattler Hypochlorite modification of sphingomyelin generates chlorinated lipid species that induce apoptosis and proteome alterations in dopaminergic PC12 neurons in vitro Free Radic. Biol. Med. 48 2010 1588 1600
102. G. Dever, L.J. Stewart, A.R. Pitt, and C.M. Spickett Phospholipid chlorohydrins cause ATP depletion and toxicity in human myeloid cells FEBS Lett. 540 2003 245 250 (Pubitemid 36398065)
103. G. Dever, C.L. Wainwright, S. Kennedy, and C.M. Spickett Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion Acta Biochim. Pol. 53 2006 761 768 (Pubitemid 46090124)
104. M.C. Vissers, A.C. Carr, and C.C. Winterbourn Fatty acid chlorohydrins and bromohydrins are cytotoxic to human endothelial cells Redox Rep. 6 2001 49 55 (Pubitemid 32331569)
105. P.S. Gargalovic, M. Imura, B. Zhang, N.M. Gharavi, M.J. Clark, J. Pagnon, W.P. Yang, A. He, A. Truong, S. Patel, S.F. Nelson, S. Horvath, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids Proc. Natl. Acad. Sci. U. S. A. 103 2006 12741 12746 (Pubitemid 44298631)
106. L. Cominacini, A. Rigoni, A.F. Pasini, U. Garbin, A. Davoli, M. Campagnola, A.M. Pastorino, V. Lo Cascio, and T. Sawamura The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide J. Biol. Chem. 276 2001 13750 13755
107. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am. J. Physiol. 271 1996 C1424 C1437
108. S. Lee, N.M. Gharavi, H. Honda, I. Chang, B. Kim, N. Jen, R. Li, A. Zimman, and J.A. Berliner A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids Free Radic. Biol. Med. 47 2009 145 151
109. N.M. Gharavi, N.A. Baker, K.P. Mouillesseaux, W. Yeung, H.M. Honda, X. Hsieh, M. Yeh, E.J. Smart, and J.A. Berliner Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids Circ. Res. 98 2006 768 776
110. M. Yeh, N. Leitinger, R. de Martin, N. Onai, K. Matsushima, D.K. Vora, J.A. Berliner, and S.T. Reddy Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 21 2001 1585 1591 (Pubitemid 34215576)
111. M. Yeh, A.L. Cole, J. Choi, Y. Liu, D. Tulchinsky, J.H. Qiao, M.C. Fishbein, A.N. Dooley, T. Hovnanian, K. Mouilleseaux, D.K. Vora, W.P. Yang, P. Gargalovic, T. Kirchgessner, J.Y. Shyy, and J.A. Berliner Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products Circ. Res. 95 2004 780 788 (Pubitemid 39390580)
112. A. Nuszkowski, R. Grabner, G. Marsche, A. Unbehaun, E. Malle, and R. Heller Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase J. Biol. Chem. 276 2001 14212 14221
113. G. Marsche, R. Heller, G. Fauler, A. Kovacevic, A. Nuszkowski, W. Graier, W. Sattler, and E. Malle 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis Arterioscler. Thromb. Vasc. Biol. 24 2004 2302 2306 (Pubitemid 39658033)
114. A. Kadl, E. Galkina, and N. Leitinger Induction of CCR2-dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation Arthritis Rheum. 60 2009 1362 1371
115. T.A. Springer Adhesion receptors of the immune system Nature 346 1990 425 434
116. M.R. Williams, V. Azcutia, G. Newton, P. Alcaide, and F.W. Luscinskas Emerging mechanisms of neutrophil recruitment across endothelium Trends Immunol. 32 2011 461 469
117. P. Alcaide, S. Auerbach, and F.W. Luscinskas Neutrophil recruitment under shear flow: it's all about endothelial cell rings and gaps Microcirculation 16 2009 43 57
118. J. Huber, A. Furnkranz, V.N. Bochkov, M.K. Patricia, H. Lee, C.C. Hedrick, J.A. Berliner, B.R. Binder, and N. Leitinger Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase J. Lipid Res. 47 2006 1054 1062 (Pubitemid 43764701)
119. S. Reddy, S. Hama, V. Grijalva, K. Hassan, R. Mottahedeh, G. Hough, D.J. Wadleigh, M. Navab, and A.M. Fogelman Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells J. Biol. Chem. 276 2001 17030 17035
120. A. Furnkranz, A. Schober, V.N. Bochkov, P. Bashtrykov, G. Kronke, A. Kadl, B.R. Binder, C. Weber, and N. Leitinger Oxidized phospholipids trigger atherogenic inflammation in murine arteries Arterioscler. Thromb. Vasc. Biol. 25 2005 633 638 (Pubitemid 40315690)
121. A.D. Watson, G. Subbanagounder, D.S. Welsbie, K.F. Faull, M. Navab, M.E. Jung, A.M. Fogelman, and J.A. Berliner Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein J. Biol. Chem. 274 1999 24787 24798
122. G. Subbanagounder, Y. Deng, C. Borromeo, A.N. Dooley, J.A. Berliner, and R.G. Salomon Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells Vascul. Pharmacol. 38 2002 201 209 (Pubitemid 36401585)
123. N. Leitinger, T.R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P.T. Shih, N. Mackman, G. Tigyi, M.C. Territo, J.A. Berliner, and D.K. Vora Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils Proc. Natl. Acad. Sci. U. S. A. 96 1999 12010 12015 (Pubitemid 29502849)
124. T.K. Hsiai, S.K. Cho, S. Reddy, S. Hama, M. Navab, L.L. Demer, H.M. Honda, and C.M. Ho Pulsatile flow regulates monocyte adhesion to oxidized lipid-induced endothelial cells Arterioscler. Thromb. Vasc. Biol. 21 2001 1770 1776 (Pubitemid 34219781)
125. L. Guo, Z. Chen, B.E. Cox, V. Amarnath, R.F. Epand, R.M. Epand, and S.S. Davies Phosphatidylethanolamines modified by gamma-ketoaldehyde (gammaKA) induce endoplasmic reticulum stress and endothelial activation J. Biol. Chem. 286 2011 18170 18180
126. B. Kiec-Wilk, A. Polus, U. Razny, U. Cialowicz, and A. Dembinska-Kiec Modulation of endothelial cell proliferation and capillary network formation by the ox-LDL component: 1-palmitoyl-2-archidonoyl-sn-glycero-3-phosphocholine (ox-PAPC) Genes Nutr. 6 2011 347 351
127. B. Pamukcu, G.Y. Lip, A. Devitt, H. Griffiths, and E. Shantsila The role of monocytes in atherosclerotic coronary artery disease Ann. Med. 42 2010 394 403
128. C.S. Kim, J.H. Kang, H.R. Cho, T.N. Blankenship, K.L. Erickson, T. Kawada, and R. Yu Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes Inflamm. Res. 60 2011 889 895
129. A. Klinke, C. Nussbaum, L. Kubala, K. Friedrichs, T.K. Rudolph, V.
130. -/- mouse arteries via upregulation of P-selectin Free Radic. Biol. Med. 44 2008 452 463
131. G. Dever, C.M. Spickett, S. Kennedy, C. Rush, G. Tennant, A. Monopoli, and C.L. Wainwright The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1alpha(betaS*, deltaS*), 2alpha, 6alpha, 8beta-(R*), 8a alpha]]-1,2,6,7,8,8a-hexahydro-beta, delta, 6-trihydroxy-2-methyl-8-(2-methyl-1- oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester)], reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice J. Pharmacol. Exp. Ther. 320 2007 419 426 (Pubitemid 46028484)
132. J.W. Chen, S.B. Zhou, and Z.M. Tan Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression, adhesion molecules and oxidative stress in human coronary artery endothelial cells Chin. Med. J. (English) 123 2010 1553 1556
133. A. Zimman, K.P. Mouillesseaux, T. Le, N.M. Gharavi, A. Ryvkin, T.G. Graeber, T.T. Chen, A.D. Watson, and J.A. Berliner Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 27 2007 332 338 (Pubitemid 46143048)
134. F. Parhami, Z.T. Fang, B. Yang, A.M. Fogelman, and J.A. Berliner Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL Arterioscler. Thromb. Vasc. Biol. 15 1995 2019 2024
135. H. Obinata, T. Hattori, S. Nakane, K. Tatei, and T. Izumi Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A J. Biol. Chem. 280 2005 40676 40683 (Pubitemid 41780559)
136. R. Li, K.P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J.A. Berliner Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC Circ. Res. 98 2006 642 650
137. Z. Honda, S. Ishii, and T. Shimizu Platelet-activating factor receptor J. Biochem. 131 2002 773 779 (Pubitemid 34717579)
138. G.K. Marathe, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidized LDL contains inflammatory PAF-like phospholipids Trends Cardiovasc. Med. 11 2001 139 142 (Pubitemid 33070337)
139. G.K. Marathe, G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre Activation of vascular cells by PAF-like lipids in oxidized LDL Vascul. Pharmacol. 38 2002 193 200 (Pubitemid 36398265)
140. S. Pegorier, D. Stengel, H. Durand, M. Croset, and E. Ninio Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages: implications in atherosclerosis Atherosclerosis 188 2006 433 443 (Pubitemid 44301144)
141. D.M. Stafforini, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes Crit. Rev. Clin. Lab. Sci. 40 2003 643 672 (Pubitemid 37491708)
142. R. Chen, X. Chen, R.G. Salomon, and T.M. McIntyre Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor Arterioscler. Thromb. Vasc. Biol. 29 2009 363 371
143. J.M. Heery, M. Kozak, D.M. Stafforini, D.A. Jones, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells J. Clin. Invest. 96 1995 2322 2330
144. N. Leitinger, A.D. Watson, K.F. Faull, A.M. Fogelman, and J.A. Berliner Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist Adv. Exp. Med. Biol. 433 1997 379 382 (Pubitemid 28231854)
145. P.L. Smiley, K.E. Stremler, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor J. Biol. Chem. 266 1991 11104 11110 (Pubitemid 21906917)
146. M.S. Gopfert, F. Siedler, W. Siess, and A. Sellmayer Structural identification of oxidized acyl-phosphatidylcholines that induce platelet activation J. Vasc. Res. 42 2005 120 132 (Pubitemid 41201977)
147. H. Suzuki, Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O. Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsumoto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, and T. Kodama A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection Nature 386 1997 292 296 (Pubitemid 27142516)
148. M. Febbraio, D.P. Hajjar, and R.L. Silverstein CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism J. Clin. Invest. 108 2001 785 791 (Pubitemid 32880285)
149. G. Endemann, L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, and A.A. Protter CD36 is a receptor for oxidized low density lipoprotein J. Biol. Chem. 268 1993 11811 11816 (Pubitemid 23168135)
150. H. Yoshida, O. Quehenberger, N. Kondratenko, S. Green, and D. Steinberg Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages Arterioscler. Thromb. Vasc. Biol. 18 1998 794 802 (Pubitemid 28267660)
151. M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 105 2000 1049 1056 (Pubitemid 30217689)
152. V.V. Kunjathoor, M. Febbraio, E.A. Podrez, K.J. Moore, L. Andersson, S. Koehn, J.S. Rhee, R. Silverstein, H.F. Hoff, and M.W. Freeman Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages J. Biol. Chem. 277 2002 49982 49988 (Pubitemid 36014449)
153. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, M. Febbraio, D.P. Hajjar, R.L. Silverstein, H.F. Hoff, R.G. Salomon, and S.L. Hazen A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions J. Biol. Chem. 277 2002 38517 38523 (Pubitemid 35154710)
154. M.E. Greenberg, M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S.L. Hazen Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells J. Exp. Med. 203 2006 2613 2625 (Pubitemid 44833338)
155. S. Kopprasch, J. Pietzsch, T. Westendorf, H.J. Kruse, and J. Grassler The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells Int. J. Biochem. Cell Biol. 36 2004 460 471 (Pubitemid 37542444)
156. G. Marsche, R. Zimmermann, S. Horiuchi, N.N. Tandon, W. Sattler, and E. Malle Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein J. Biol. Chem. 278 2003 47562 47570 (Pubitemid 37523199)
157. G. Marsche, A. Hammer, O. Oskolkova, K.F. Kozarsky, W. Sattler, and E. Malle Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport J. Biol. Chem. 277 2002 32172 32179 (Pubitemid 34969031)
158. J.D. Tugwood, I. Issemann, R.G. Anderson, K.R. Bundell, W.L. McPheat, and S. Green The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene EMBO J. 11 1992 433 439
159. V.R. Babaev, H. Ishiguro, L. Ding, P.G. Yancey, D.E. Dove, W.J. Kovacs, C.F. Semenkovich, S. Fazio, and M.F. Linton Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 116 2007 1404 1412 (Pubitemid 47417567)
160. D. Namgaladze, D. Morbitzer, A. von Knethen, and B. Brune Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors Arterioscler. Thromb. Vasc. Biol. 30 2010 313 320
161. H. Lee, W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C.C. Hedrick, S. Hama, C. Borromeo, R.M. Evans, J.A. Berliner, and L. Nagy Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells Circ. Res. 87 2000 516 521
162. K. Taketa, T. Matsumura, M. Yano, N. Ishii, T. Senokuchi, H. Motoshima, Y. Murata, S. Kim-Mitsuyama, T. Kawada, H. Itabe, M. Takeya, T. Nishikawa, K. Tsuruzoe, and E. Araki Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages J. Biol. Chem. 283 2008 9852 9862
163. S.S. Davies, A.V. Pontsler, G.K. Marathe, K.A. Harrison, R.C. Murphy, J.C. Hinshaw, G.D. Prestwich, A.S. Hilaire, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists J. Biol. Chem. 276 2001 16015 16023
164. J. Barlic, Y. Zhang, J.F. Foley, and P.M. Murphy Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway Circulation 114 2006 807 819 (Pubitemid 44268231)
165. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252 (Pubitemid 28180857)
166. L. Nagy, P. Tontonoz, J.G. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 93 1998 229 240 (Pubitemid 28180856)
167. P. Tobias, and L.K. Curtiss The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J. Lipid Res. 46 2005 404 411 (Pubitemid 43109775)
168. Y.I. Miller, S. Viriyakosol, D.S. Worrall, A. Boullier, S. Butler, and J.L. Witztum Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages Arterioscler. Thromb. Vasc. Biol. 25 2005 1213 1219 (Pubitemid 40776611)
169. K.A. Walton, X. Hsieh, N. Gharavi, S. Wang, G. Wang, M. Yeh, A.L. Cole, and J.A. Berliner Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl- sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8: a role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein J. Biol. Chem. 278 2003 29661 29666 (Pubitemid 36962351)
170. L. Verstrepen, T. Bekaert, T.L. Chau, J. Tavernier, A. Chariot, and R. Beyaert TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme Cell. Mol. Life Sci. 65 2008 2964 2978
171. C. Erridge, D.J. Webb, and C.M. Spickett Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression Atherosclerosis 193 2007 77 85 (Pubitemid 46776713)
172. C. Erridge, S. Kennedy, C.M. Spickett, and D.J. Webb Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition J. Biol. Chem. 283 2008 24748 24759
173. Y. Imai, K. Kuba, G.G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y.H. Leung, H. Wang, H. Liu, Y. Sun, M. Pasparakis, M. Kopf, C. Mech, S. Bavari, J.S. Peiris, A.S. Slutsky, S. Akira, M. Hultqvist, R. Holmdahl, J. Nicholls, C. Jiang, C.J. Binder, and J.M. Penninger Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 133 2008 235 249 (Pubitemid 351512299)
174. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, S. Tsimikas, D. Golenbock, K.J. Moore, and I. Tabas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
175. W. Tseng, J. Lu, G.A. Bishop, A.D. Watson, A.P. Sage, L. Demer, and Y. Tintut Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids J. Lipid Res. 51 2010 1010 1016
176. V.N. Bochkov, A. Kadl, J. Huber, F. Gruber, B.R. Binder, and N. Leitinger Protective role of phospholipid oxidation products in endotoxin-induced tissue damage Nature 419 2002 77 81 (Pubitemid 34987873)
177. E. von Schlieffen, O.V. Oskolkova, G. Schabbauer, F. Gruber, S. Bluml, M. Genest, A. Kadl, C. Marsik, S. Knapp, J. Chow, N. Leitinger, B.R. Binder, and V.N. Bochkov Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 29 2009 356 362
178. S. Bluml, S. Kirchberger, V.N. Bochkov, G. Kronke, K. Stuhlmeier, O. Majdic, G.J. Zlabinger, W. Knapp, B.R. Binder, J. Stockl, and N. Leitinger Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40 J. Immunol. 175 2005 501 508 (Pubitemid 40884355)
179. Z. Ma, J. Li, L. Yang, Y. Mu, W. Xie, B. Pitt, and S. Li Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids Am. J. Physiol. Lung Cell. Mol. Physiol. 286 2004 L808 L816
180. O.V. Oskolkova, T. Afonyushkin, B. Preinerstorfer, W. Bicker, E. von Schlieffen, E. Hainzl, S. Demyanets, G. Schabbauer, W. Lindner, A.D. Tselepis, J. Wojta, B.R. Binder, and V.N. Bochkov Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation J. Immunol. 185 2010 7706 7712
181. S. Knapp, U. Matt, N. Leitinger, and T. van der Poll Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo J. Immunol. 178 2007 993 1001 (Pubitemid 46095173)
182. K.G. Birukov, V.N. Bochkov, A.A. Birukova, K. Kawkitinarong, A. Rios, A. Leitner, A.D. Verin, G.M. Bokoch, N. Leitinger, and J.G. Garcia Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac Circ. Res. 95 2004 892 901 (Pubitemid 39435004)
183. S. Nonas, I. Miller, K. Kawkitinarong, S. Chatchavalvanich, I. Gorshkova, V.N. Bochkov, N. Leitinger, V. Natarajan, J.G. Garcia, and K.G. Birukov Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury Am. J. Respir. Crit. Care Med. 173 2006 1130 1138 (Pubitemid 43726894)
184. A.A. Birukova, S. Chatchavalvanich, O. Oskolkova, V.N. Bochkov, and K.G. Birukov Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection Microvasc. Res. 73 2007 173 181 (Pubitemid 46604761)
185. A.A. Birukova, I. Malyukova, A. Mikaelyan, P. Fu, and K.G. Birukov Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids J. Cell. Physiol. 211 2007 608 617 (Pubitemid 46683029)
186. A.A. Birukova, N. Zebda, P. Fu, V. Poroyko, I. Cokic, and K.G. Birukov Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids J. Cell. Physiol. 226 2011 2052 2062
187. D.R. Moellering, A.L. Levonen, Y.M. Go, R.P. Patel, D.A. Dickinson, H.J. Forman, and V.M. Darley-Usmar Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonyl phosphatidylcholine: protection against quinone-mediated oxidative stress Biochem. J. 362 2002 51 59 (Pubitemid 34174461)
188. H.K. Jyrkkanen, E. Kansanen, M. Inkala, A.M. Kivela, H. Hurttila, S.E. Heinonen, G. Goldsteins, S. Jauhiainen, S. Tiainen, H. Makkonen, O. Oskolkova, T. Afonyushkin, J. Koistinaho, M. Yamamoto, V.N. Bochkov, S. Yla-Herttuala, and A.L. Levonen Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo Circ. Res. 103 2008 e1 e9
189. C. Code, A.K. Mahalka, K. Bry, and P.K. Kinnunen Activation of phospholipase A2 by 1-palmitoyl-2-(9′-oxo-nonanoyl)-sn-glycero-3- phosphocholine in vitro Biochim. Biophys. Acta 1798 2010 1593 1600
190. E. Feige, I. Mendel, J. George, N. Yacov, and D. Harats Modified phospholipids as anti-inflammatory compounds Curr. Opin. Lipidol. 21 2010 525 529